Health Care Technology

Citi is maintaining its Buy rating on shares of Cerner Corp. (NASDAQ: CERN). “Cerner's investor conference left us more comfortable with the company's long term growth opportunity, especially knowing how many levers the company has to continue its top line growth,” Citi writes. “CERN shares trade...

J.P. Morgan is maintaining its Overweight rating on shares of Cerner Corp. (NASDAQ: CERN). “We continue to like CERN shares given the near-term opportunity over the next 2-3 years presented by the stimulus, as well as an emerging longer-term strategy which could sustain earnings growth in the high-...

Piper Jaffray is reiterating its Overweight rating and $108 price target on shares of Cerner Corporation (NASDAQ: CERN). In a note to investors, Piper Jaffray writes, "As expected, the company did not update guidance by reiterating current FY11 guidance. Rather, the company focused on...

Shares of MedAssets, Inc. (NASDAQ: MDAS) are higher on the session by 1.86%, trading at $15.86. Overall call volume is now running at 6.56x the daily average, with 84% of all calls traded being purchases on the offer. 1,267 contracts have traded on the session so far. MedAssets, Inc. provides...

A few stocks are making all-time highs today. Cerner Corporation (NASDAQ: CERN) is up $2.18 to $104.05, a gain of 2.1% on a little less than 200,000 shares. Cerner Corporation provides healthcare information technology, healthcare devices, and content solutions for healthcare organizations and...

Shares of MedAssets (NASDAQ: MDAS) are higher on the session by 0.36%, currently trading at $14.11. The stock has been moving largely lower over the past four months and is currently trading below the 50-day and 200-day moving averages. Options traders are buying puts on the name today. A short...

Citi is downgrading MedAssets (NASDAQ: MDAS) to Hold from Buy following Q4 results that were very disappointing, largely due to company-specific concerns. MedAssets reported Q4 net operating EPS of $0.18, vs. our/Street $0.22. Nearly every line item was below expectations, with lower profitability...

Deutsche Bank has lowered the price target on MedAssets (NASDAQ: MDAS) from $27 to $19 and maintains its Hold rating.

First Solar Inc (NASDAQ: FSLR) was downgraded by UBS from "buy" to "neutral." FSLR's shares closed at $164.68 yesterday. First Solar's trailing-twelve-month ROA is 13.01%. Deutsche Bank downgraded RailAmerica Inc (NYSE: RA) from “buy” to “hold.” RA' stock closed at $14.48 yesterday. RailAmerica's...

Pre-open movers US stock futures are higher this morning as crude oil prices stabilized. Investors are awaiting economic reports. Futures for the Dow Jones Industrial Average gained 78 points to 12,115, while those for the S&P 500 index climbed 9.60 points to 1,312. Futures for the Nasdaq 100...

Citigroup has downgraded MedAssets (NASDAQ: MDAS) from Buy to Hold and has lowered the price target from $26 to $20.

Auriga is lowering its PT on shares of MedAssets, Inc. (NASDAQ: MDAS) from $26 to $22. MedAssets closed Thursday at $21.32.

Piper Jaffray, which downgraded shares of MedAssets, Inc. (NASDAQ: MDAS) – and lowered its PT from $21 to $15 – is providing some color on its 4Q results. “MDAS Q4 earnings missed on the top and bottom line, they guided below our street-low 2011 estimates, RCM backlog showed no growth,” Piper...

Piper Jaffray has downgraded MedAssets, Inc. (NASDAQ: MDAS) from Neutral to Underweight and has lowered the price target from $21 to $15.

Analysts at Citigroup downgrade MedAssets Inc (NASDAQ: MDAS) from “buy” to “hold.” The target price for MDAS has been lowered from $26 to $20. MDAS shares gained 3.44% to close at $21.32 yesterday. More Analyst Ratings here